Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Udp-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 9 (GalNAc-T9) (GALNT9) (C-Term) Peptide

GALNT9 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN2184647
  • Antigène Tous les produits GALNT9
    GALNT9 (Udp-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 9 (GalNAc-T9) (GALNT9))
    Protein Region
    C-Term
    Origine
    Humain
    Source
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Séquence
    DFGDVSERLA LRQRLKCRSF KWYLENVYPE MRVYNNTLTY GEVRNSKASA
    Attributs du produit
    This is a synthetic peptide designed for use in combination with anti-GALNT9 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Conseil sur la manipulation
    Avoid repeat freeze-thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène
    GALNT9 (Udp-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 9 (GalNAc-T9) (GALNT9))
    Synonymes
    GALNT9 Peptide, 6430598F23 Peptide, GalNAc-T9 Peptide, GALNAC-T9 Peptide, GALNACT9 Peptide, polypeptide N-acetylgalactosaminyltransferase 9 Peptide, GALNT9 Peptide, LOC710382 Peptide, LOC749939 Peptide, galnt9 Peptide, Galnt9 Peptide
    Sujet
    This gene encodes a member of the UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes. GalNAc-Ts initiate mucin-type O-linked glycosylation in the Golgi apparatus by catalyzing the transfer of GalNAc to serine and threonine residues on target proteins. They are characterized by an N-terminal transmembrane domain, a stem region, a lumenal catalytic domain containing a GT1 motif and Gal/GalNAc transferase motif, and a C-terminal ricin/lectin-like domain. GalNAc-Ts have different, but overlapping, substrate specificities and patterns of expression. This gene is expressed specifically in the brain, with highest expression in the cerebellum. Multiple transcript variants encoding different isoforms have been found for this gene.

    Alias Symbols: GALNAC-T9

    Protein Size: 603
    Poids moléculaire
    66 kDa
    ID gène
    50614
    NCBI Accession
    NM_001122636, NP_001116108
    UniProt
    J3KNN1
Vous êtes ici:
Support technique